Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children
Keywords: ADCC; Antibody-dependent cellular cytotoxicity; AIHA; Autoimmune hemolytic anemia; ALL; Acute lymphoblastic leukemia; CR; Complete response; IFN; Interferon; IL; Interleukin; ITP; Immune thrombocytopenic purpura; IVIG; Intravenous immune globulin; NHL; No